Morgan Roberts
Research Classification
Research Interests
Immunology
Bladder cancer
Immuno-oncology
Sex differences in cancer immunobiology
Affiliations to Research Centres, Institutes & Clusters
Research Options
I am available and interested in collaborations (e.g. clusters, grants).
I am interested in and conduct interdisciplinary research.
I am interested in working with undergraduate students on research projects.
Research Methodology
High parameter flow cytometry
orthotopic models of bladder cancer
Publications
- Development of a bispecific immune engager using a recombinant malaria protein. (2021)
Cell death & disease, - Deep Phenotyping by Mass Cytometry and Single Cell RNA-Sequencing Reveals LYN Regulated Signaling Profiles Underlying Monocyte Subset Heterogeneity and Lifespan. (2020)
Circulation research, - UV‐induced DNA damage response in blood cells for cancer detection (2020)
MEDICAL DEVICES & SENSORS, - Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma. (2020)
Journal of experimental & clinical cancer research : CR, - Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis (2018)
Frontiers in Immunology, 9 - Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer (2017)
Nature Communications, 8 (1) - Targeting Lyn regulates Snail family shuttling and inhibits metastasis (2017)
Oncogene, - Recent progress with next-generation biomarkers in muscle-invasive bladder cancer (2016)
International Journal of Urology, 24 (1), 7--15 - PD-L1 is highly expressed in Enzalutamide resistant prostate cancer (2015)
Oncotarget, - Lyn Deficiency Leads to Increased Microbiota-Dependent Intestinal Inflammation and Susceptibility to Enteric Pathogens (2014)
The Journal of Immunology, 193 (10), 5249--5263 - Dysregulated Hematopoiesis Caused by Mammary Cancer Is Associated with Epigenetic Changes and Hox Gene Expression in Hematopoietic Cells (2013)
Cancer Research, 73 (19), 5892--5904 - Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells (2013)
Mucosal Immunology, 7 (2), 405--416 - PD-L1 is highly expressed in Enzalutamide resistant prostate cancer (2010)
Oncotarget, 1 (1), 234--242
If this is your researcher profile you can log in to the Faculty & Staff portal to update your details and provide recruitment preferences.
